MMJ International Holdings Exposes the Impossible Federal Catch-22 Blocking FDA Regulated Cannabis Medicine. “This is an equation with no solution. To follow the rule is to commit a felony, and to ...

Phoenix NP announced an expansion of its service availability across Arizona to help more women access FDA-approved GLP-1 weight loss medications through compliant, manufacturer-direct pharmacies. The ...

Jaguar’s requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia® A ...

ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

The U.S. government says a preventative drug is effective in treating New World screwworm infestations in cats, particularly ...

A once-beleaguered gene-therapy stock just landed a major vote of confidence—and the timing seems anything but accidental.

A new type of lens approved by the FDA promises to slow nearsightedness in children and reduce the progression of myopia in ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:00 AM ESTCompany ParticipantsLauren Tengler - ...

Vorasidenib significantly reduced tumor growth rates in IDH1/2-mutant grade 2 glioma, improving PFS and TTNI compared to ...

FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.